Gender differences in the prevalence, risk and clinical correlates of tardive dyskinesia in Chinese schizophrenia

Psychopharmacology

Volumn 205, Issue 4, 2009, Pages 647-654

  Zhang, Xiang Yang ^a,b,c   Chen, Da Chun ^b   Qi, Ling Yan ^b   Wang, Fang ^b   Xiu, Mei Hong ^b   Chen, Song ^b   Wu, Gui Ying ^a   Kosten, Therese A ^c   Kosten, Thomas R ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b BEIJING HUILONGGUAN HOSPITAL   (China)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antipsychotic; Chinese; Gender difference; Prevalence; Risk factor; Schizophrenia; Tardive dyskinesia

Indexed keywords

ANTIPARKINSON AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; PERPHENAZINE; RISPERIDONE; SULPIRIDE;

ABNORMAL INVOLUNTARY MOVEMENT SCALE; ADULT; AGED; ARTICLE; CHINESE; CLINICAL ASSESSMENT; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; GENDER; HOSPITAL PATIENT; HUMAN; INFORMATION PROCESSING; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MENTAL DISEASE; MENTAL PATIENT; POSITIVE AND NEGATIVE SYNDROME SCALE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; RISK; SCHIZOPHRENIA; SCORING SYSTEM; SEX DIFFERENCE; SYMPTOM; TARDIVE DYSKINESIA;

ADULT; AGE FACTORS; AGED; ANTIPSYCHOTIC AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; CROSS-SECTIONAL STUDIES; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; SEX CHARACTERISTICS;

EID: 68149162730     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1590-8     Document Type: Article

References (51)

1. American Psychiatric Association (2004) Practice Guidelines for the Treatment of Patients with Schizophrenia. American Psychiatric, Washington DC
2. RJ Baldessarini 1985 Clinical and epidemiologic aspects of tardive dyskinesia J Clin Psychiatry 46 8 13
3. J Ballesteros A Gonzalez-Pinto A Bulbena 2000 Tardive dyskinesia associated with higher mortality in psychiatric patients: results of a meta-analysis of seven independent studies J Clin Psychopharmacol 20 188 194
4. L Bertilsson ML Dahl P Dalén A Al-Shurbaji 2002 Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs Br J Clin Pharmacol 53 111 122
5. L Bertilsson 2007 Metabolism of Antidepressant and Neuroleptic Drugs by Cytochrome P450s: Clinical and Interethnic Aspects Clin Pharmacol Ther 82 606 609
6. S Browne M Roe A Lane M Gervin M Morris A Kinsella C Larkin EO Callaghan 1996 Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia Acta Psychiatr Scand 94 118 124
7. MP Caligiuri JP Lacro E Rockwell LA [tmp] McAdams DV Jeste 1997 Incidence and risk factors for severe tardive dyskinesia in older patients Br J Psychiatry 171 148 153
8. DE Casey 1997 Will the new antipsychotics bring hope of reducing the risk of developing extrapyramidal syndromes and tardive dyskinesia? Int Clin Psychopharmacol 12 Suppl 1 S19 S27
9. DE Casey 1999 Tardive dyskinesia and atypical tipsychotic drugs Schizophr Res 35 Suppl S61 S66
10. HF Chiu YK Wing PK Kwong CM Leung LC Lam 1993 Prevalence of tardive dyskinesia in samples of elderly people in Hong Kong Acta Psychiatr Scand 87 266 268
11. H Chiu P Shum J Lau L Lam S Lee 1992 Prevalence of tardive dyskinesia, tardive dystonia, and respiratory dyskinesia among Chinese psychiatric patients in Hong Kong Am J Psychiatry 149 1081 1085
12. SA Chong R Mahendran D Machin HC Chua G Parker J Kane 2002 Tardive dyskinesia among Chinese and Malay patients with schizophrenia J Clin Psychopharmacol 22 26 30
13. CU Correll EM Schenk 2008 Tardive dyskinesia and new antipsychotics Curr Opin Psychiatry 21 151 156
14. J de Leon 2007 The effect of atypical versus typical antipsychotics on tardive dyskinesia: a naturalistic study Eur Arch Psychiatry Clin Neurosci 257 169 172
15. WS Fenton RJ Wyatt TH [tmp] McGlashan 1994 Risk factors for spontaneous dyskinesia in schizophrenia Arch Gen Psychiatry 51 643 650
16. WM Glazer 2000 Review of incidence studies of tardive dyskinesia associated with typical antipsychotics J Clin Psychiatry 61 Suppl 4 15 20
17. WM Glazer 2000 Expected incidence of tardive dyskinesia associated with atypical antipsychotics J Clin Psychiatry 61 Suppl 4 21 26
18. Guy W (1976) ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-388. US Department of Health, Education, and Welfare
19. JM Gold MF Egan DG Kirch TE Goldberg DG Daniel LB Bigelow RJ Wyatt 1991 Tardive dyskinesia: neuropsychological, computerized tomographic, and psychiatric symptom findings Biol Psychiatry 30 587 599
20. DV Jeste MP Caligiuri JS Paulsen RK Heaton JP Lacro MJ Harris A Bailey RL Fell LA [tmp] McAdams 1995 Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients Arch Gen Psychiatry 52 756 765
21. DV Jeste 2004 Tardive dyskinesia rates with atypical antipsychotics in older adults J Clin Psychiatry 65 Suppl 9 21 22
22. JM Kane JM Smith 1982 Tardive dyskinesia: prevalence and risk factors, 1959 to 1979 Arch Gen Psychiatry 39 473 481
23. JM Kane M Woerner M Borenstein J Wegner J Lieberman 1986 Integrating incidence and prevalence of tardive dyskinesia Psychopharmacol Bull 22 254 258
24. JM Kane 2004 Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence J Clin Psychiatry 65 Suppl 9 6 20
25. S Kasper AJ Lowry A Hodge I Bitter M Dossenbach 2006 Tardive dyskinesia: analysis of outpatients with schizophrenia from Africa and the Middle East, Asia, Central and Eastern Europe, and Latin America Schizophr Res 81 139 143
26. SR Kay A Fiszbein LA Opler 1987 The positive and negative syndrome scale (PANSS) for schizophrenia Schizophr Bull 13 261 276
27. GN Ko LD Zhang WW Yan MD Zhang D Buchner ZY Xia RJ Wyatt DV Jeste 1989 The Shanghai 800: prevalence of tardive dyskinesia in a Chinese psychiatric hospital Am J Psychiatry 146 387 389
28. A Leung P Chue 2000 Sex differences in schizophrenia, a review of the literature Acta Psychiatr Scand Suppl 401 3 38
29. PF Liddle TR Barnes J Speller D Kibel 1993 Negative symptoms as a risk factor for tardive dyskinesia in schizophrenia Br J Psychiatry 163 776 780
30. JB Lohr R Kuczenski AB Niculescu 2003 Oxidative mechanisms and tardive dyskinesia CNS Drugs 17 47 62
31. RG [tmp] McCreadie R Thara S Kamath R Padmavathy S Latha N Mathrubootham MS Menon 1996 Abnormal movements in never-medicated Indian patients with schizophrenia Br J Psychiatry 168 221 226
32. H Morgenstern WM Glazer 1993 Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. results of the yale Tardive Dyskinesia study Arch Gen Psychiatry 50 723 733
33. A Nilsson L Waller A Rosengren A Adlerberth L Wilhelmsen 1997 Cigarette smoking is associated with abnormal involuntary movements in the general male population-a study of men born in 1933 Biol Psychiatry 41 717 723
34. BD Patterson D Swingler S Willows 2005 Prevalence of and risk factors for tardive dyskinesia in a Xhosa population in the Eastern Cape of South Africa Schizophr Res 76 89 97
35. EH Pi MA Gutierrez GE Gray 1993 Cross-cultural studies in tardive dyskinesia Am J Psychiatry 150 991
36. G Remington 2007 Tardive dyskinesia: eliminated, forgotten, or overshadowed? Curr Opin Psychiatry 20 131 137
37. PS Sachdev 2000 The current status of tardive dyskinesia Aust N Z J Psychiatry 34 355 369
38. NR Schooler JM Kane 1982 Research diagnoses for tardive dyskinesia Arch Gen Psychiatry 39 486 487
39. KV Soares JJ [tmp] McGrath 1999 The treatment of tardive dyskinesia: a systematic review and metaanalysis Schizophr Res 39 1 16
40. CA Tamminga 1997 Gender and schizophrenia J Clin Psychiatry 58 Suppl 15 33 37
41. CH Tan LK Tay 1991 Tardive dyskinesia in elderly psychiatric patients in Singapore Aust N Z J Psychiatry 25 119 122
42. B Thelma V Srivastava AK Tiwari 2008 Genetic underpinnings of tardive dyskinesia: passing the baton to pharmacogenetics Pharmacogenomics 9 1285 306
43. PN van Harten HW Hoek GE Matroos J van Os 2006 Incidence of tardive dyskinesia and tardive dystonia in African Caribbean patients on long-term antipsychotic treatment: the Curaçao extrapyramidal syndromes study V J Clin Psychiatry 67 1920 1927
44. J van Os T Fahy P Jones I Harvey B Toone R Murray 1997 Tardive dyskinesia: who is at risk? Acta Psychiatr Scand 96 206 216
45. J van Os E Walsh E van Horn T Tattan R Bale SG Thompson 2000 Changes in negative symptoms and the risk of tardive dyskinesia: a longitudinal study. UK700 Group Acta Psychiatr Scand 101 300 306
46. MG Woerner JM Kane JA Lieberman J Alvir KJ Bergmann M Borenstein NR Schooler S Mukherjee J Rotrosen M Rubinstein 1991 The prevalence of tardive dyskinesia J Clin Psychopharmacol 11 34 42
47. SW Woods 2003 Chlorpromazine equivalent doses for the newer atypical antipsychotics J Clin Psychiatry 64 663 667
48. BA Wszola KM Newell RL Sprague 2001 Risk factors for tardive dyskinesia in a large population of youths and adults Exp Clin Psychopharmacol 9 285 296
49. R Yassa DV Jeste 1992 Gender differences in tardive dyskinesia: a critical review of the literature Schizophr Bull 18 701 715
50. HA Youssef JL Waddington 1987 Morbidity and mortality in tardive dyskinesia: associations in chronic schizophrenia Acta Psychiatr Scand 75 74 77
51. O Yuen MP Caligiuri R Williams RA Dickson 1996 Tardive dyskinesia and positive and negative symptoms of schizophrenia. A study using instrumental measures Br J Psychiatry 168 702 708